| 000 | 01392 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513114215.0 | ||
| 264 | 0 | _c19970714 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0272-5231 | ||
| 024 | 7 |
_a10.1016/s0272-5231(05)70360-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBishai, W R | |
| 245 | 0 | 0 |
_aShort-course chemoprophylaxis for tuberculosis. _h[electronic resource] |
| 260 |
_bClinics in chest medicine _cMar 1997 |
||
| 300 |
_a115-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 | _aAntibiotic Prophylaxis |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xgenetics |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xepidemiology |
| 700 | 1 | _aChaisson, R E | |
| 773 | 0 |
_tClinics in chest medicine _gvol. 18 _gno. 1 _gp. 115-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-5231(05)70360-9 _zAvailable from publisher's website |
| 999 |
_c9081196 _d9081196 |
||